The study by Stupp et al. did not consider IDH1 or MGMT status; in addition, 15% of their patients did not have the histological diagnosis confirmed and of those that did, 8% were found to have a diagnosis other than GBM. This evidence concerns the gene MGMT and glioblastoma.